Successful Treatment of Female Pattern Hair Loss with Injection of Autologous Adipose-derived Adult Stem Cells: A Controlled Clinical, Trichoscopic, and Immunohistochemical Trial.
Moneib H., Fathy G., Samir NA., El-Khazragy N., El-Bassiouny M.
Randomized Controlled Trial with a reported sample of 33 on Hair Loss, Hair Regeneration, published in Int J Trichology (2025) — summary generated from the PubMed abstract.
Several human studies show positive signals, while research methods and sample sizes continue to develop.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Randomized Controlled Trial
- Journal
- Int J Trichology (2025)
- Country
- India
- Reported sample size
- 33
- Source database
- PubMed
- PMID
- 41306847
- PMCID
- PMC12646523
- DOI
- 10.4103/ijt.ijt_129_23
Abstract (original English)
Background Hair follicles undergo growth, regression, and quiescence. It is suspected that adipocytes secrete factors that promote the activation of follicular dermal papilla cells, increase migration and proliferation in vitro , and increase the conversion of hair follicles from the telogen to anagen phase in vivo . Objectives To evaluate the efficacy of adipose derived stem cells (ADSCs) injection for the treatment of female pattern hair loss (FPHL). Patients and methods This prospective randomized controlled trial included 33 patients divided into three groups according to Sinclair classification. ADSCs were extracted from autologous fat obtained from the lipoaspirate, cultured, and injected into the frontoparietal scalp. The patients were assessed clinically, trichoscopically, histopathologically, and immunohistochemically for hair cycle markers. Results At weeks 12 and 24, there was an improvement in hair thickness and count, and an increased number of hairs per follicular unit. Histopathological and immunohistochemical assessments at week 12 showed a decrease in perifollicular inflammation, an increase in the hair cycle stimulatory marker (follistatin), and a decrease in hair cycle suppressor (DKK-1) immunostaining. Conclusion The use of ADSCs in subjects with FPHL included in this study showed increased hair density and thickness, improved perifollicular inflammation, an
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
Evidence level
Several human studies show positive signals, while research methods and sample sizes continue to develop.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.
Related research
- Level ASystematic ReviewEurope PMC
The suitability of mesenchymal stem cells for treating immune-mediated inflammatory skin diseases: a systematic review
Systematic Review with a reported sample of 609 on Hair Loss, Immune Modulation, Autoimmune Research, published in Dermatol Reports (2026) — summary generated from the PubMed abstract.
- 2026
- n = 609
Dermatol Reports - Level ASystematic ReviewPubMed
A systematic review of clinical evidence on the efficacy and safety of conditioned media, platelet-rich fibrin, stromal vascular fraction, extracellular vesicles, and stem cells in androgenetic alopecia.
Systematic Review with a reported sample of 724 on Hair Loss, Hair Regeneration, published in Stem Cell Res Ther (2026) — summary generated from the PubMed abstract.
- 2026
- n = 724
Stem Cell Res Ther - Level AMeta-analysisEurope PMC
DKK3-CKAP4 signaling drives fibroimmune remodeling and hair follicle miniaturization in androgenetic alopecia
Meta-analysis on Hair Loss, Hair Regeneration, published in Theranostics (2026) — summary generated from the PubMed abstract.
- 2026
Theranostics - Level AMeta-analysisEurope PMC
Systematic review and meta-analysis of the use of micrografting technology in humans
Meta-analysis with a reported sample of 24 on Chronic Wound, Burns, Hair Loss, published in J Int Med Res (2025) — summary generated from the PubMed abstract.
- 2025
- n = 24
J Int Med Res1 citations - Level ASystematic ReviewEurope PMC
Therapeutic potential of stem cell-derived exosomes in hair regeneration: A systematic review
Systematic Review on Hair Loss, Hair Regeneration, published in World J Stem Cells (2025) — summary generated from the PubMed abstract.
- 2025
World J Stem Cells2 citations - Level ASystematic ReviewPubMed
Exosomes and Hair Regeneration: A Systematic Review of Clinical Evidence Across Alopecia Types and Exosome Sources.
Systematic Review on Hair Loss, Hair Regeneration, published in Clin Cosmet Investig Dermatol (2025) — summary generated from the PubMed abstract.
- 2025
Clin Cosmet Investig Dermatol6 citations